Literature DB >> 23764825

The association between premature plantarflexor muscle activity, muscle strength, and equinus gait in patients with various pathologies.

Katrin Schweizer1, Jacqueline Romkes, Reinald Brunner.   

Abstract

This study provides an overview on the association between premature plantarflexor muscle activity (PPF), muscle strength, and equinus gait in patients with various pathologies. The purpose was to evaluate whether muscular weakness and biomechanical alterations are aetiological factors for PPF during walking, independent of the underlying pathology. In a retrospective design, 716 patients from our clinical database with 46 different pathologies (orthopaedic and neurologic) were evaluated. Gait analysis data of the patients included kinematics, kinetics, electromyographic activity (EMG) data, and manual muscle strength testing. All patients were clustered three times. First, patients were grouped according to their primary pathology. Second, all patients were again clustered, this time according to their impaired joints. Third, groups of patients with normal EMG or PPF, and equinus or normal foot contact were formed to evaluate the association between PPF and equinus gait. The patient groups derived by the first two cluster methods were further subdivided into patients with normal or reduced muscle strength. Additionally, the phi correlation coefficient was calculated between PPF and equinus gait. Independent of the clustering, PPF was present in all patient groups. Weak patients revealed PPF more frequently. The correlations of PPF and equinus gait were lower than expected, due to patients with normal EMG during loading response and equinus. These patients, however, showed higher gastrocnemius activity prior to foot strike together with lower peak tibialis anterior muscle activity in loading response. Patients with PPF and a normal foot contact possibly apply the plantarflexion-knee extension couple during loading response. While increased gastrocnemius activity around foot strike seems essential for equinus gait, premature gastrocnemius activity does not necessarily produce an equinus gait. We conclude that premature gastrocnemius activity is strongly associated with muscle weakness. It helps to control the knee joint under load independent from the underlying disease, and it is therefore a secondary deviation. If treated as primary target, caution should be exercised.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dynamic electromyography; Equinus gait; Gait deviation; Muscle weakness; Premature plantarflexor activity

Mesh:

Year:  2013        PMID: 23764825     DOI: 10.1016/j.ridd.2013.05.025

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  5 in total

1.  Feedforward neural control of toe walking in humans.

Authors:  Jakob Lorentzen; Maria Willerslev-Olsen; Helle Hüche Larsen; Christian Svane; Christian Forman; Rasmus Frisk; Simon Francis Farmer; Uwe Kersting; Jens Bo Nielsen
Journal:  J Physiol       Date:  2018-04-15       Impact factor: 5.182

Review 2.  [Principles of treatment of spastic palsy in children: a critical review].

Authors:  R Brunner
Journal:  Orthopade       Date:  2014-07       Impact factor: 1.087

Review 3.  Best clinical practice in botulinum toxin treatment for children with cerebral palsy.

Authors:  Walter Strobl; Tim Theologis; Reinald Brunner; Serdar Kocer; Elke Viehweger; Ignacio Pascual-Pascual; Richard Placzek
Journal:  Toxins (Basel)       Date:  2015-05-11       Impact factor: 4.546

4.  Radiological outcome after treatment of juvenile flatfeet with subtalar arthroereisis: a matched pair analysis of 38 cases comparing neurogenic and non-neurogenic patients.

Authors:  H Kubo; R Krauspe; M Hufeland; C Lipp; M Ruppert; B Westhoff; H Pilge
Journal:  J Child Orthop       Date:  2019-08-01       Impact factor: 1.548

5.  Altered Muscle Contributions are Required to Support the Stance Limb During Voluntary Toe-Walking.

Authors:  Enrico De Pieri; Jacqueline Romkes; Christian Wyss; Reinald Brunner; Elke Viehweger
Journal:  Front Bioeng Biotechnol       Date:  2022-04-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.